USANA Health Sciences, Inc. (NYSE:USNA) CEO Jim Brown Sells 5,000 Shares

USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) CEO Jim Brown sold 5,000 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $29.47, for a total value of $147,350.00. Following the sale, the chief executive officer now directly owns 15,716 shares of the company's stock, valued at $463,150.52. The trade was a 24.14 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

USANA Health Sciences Stock Up 1.4 %

NYSE USNA traded up $0.44 during midday trading on Friday, hitting $32.93. The company had a trading volume of 235,379 shares, compared to its average volume of 176,186. The firm has a fifty day simple moving average of $33.02 and a two-hundred day simple moving average of $36.27. USANA Health Sciences, Inc. has a fifty-two week low of $27.71 and a fifty-two week high of $50.32. The stock has a market cap of $627.70 million, a price-to-earnings ratio of 11.64, a P/E/G ratio of 0.93 and a beta of 0.98.

USANA Health Sciences (NYSE:USNA - Get Free Report) last released its earnings results on Tuesday, February 25th. The company reported $0.64 earnings per share for the quarter, topping analysts' consensus estimates of $0.49 by $0.15. The business had revenue of $213.61 million for the quarter, compared to the consensus estimate of $208.82 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. As a group, equities analysts predict that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Remove Ads

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. Sidoti lowered shares of USANA Health Sciences from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, February 18th. StockNews.com downgraded USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a research note on Friday, February 14th. Finally, DA Davidson dropped their price target on USANA Health Sciences from $38.00 to $36.00 and set a "neutral" rating on the stock in a research report on Thursday, February 27th.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Public Employees Retirement System of Ohio increased its holdings in USANA Health Sciences by 635.5% in the 4th quarter. Public Employees Retirement System of Ohio now owns 5,075 shares of the company's stock valued at $182,000 after buying an additional 4,385 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in USANA Health Sciences by 83.6% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 17,300 shares of the company's stock valued at $621,000 after acquiring an additional 7,877 shares during the period. Millennium Management LLC acquired a new position in USANA Health Sciences in the fourth quarter worth about $633,000. Lazard Asset Management LLC raised its position in USANA Health Sciences by 24,765.5% in the fourth quarter. Lazard Asset Management LLC now owns 7,211 shares of the company's stock worth $258,000 after purchasing an additional 7,182 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. lifted its stake in USANA Health Sciences by 16.7% during the fourth quarter. Jacobs Levy Equity Management Inc. now owns 128,976 shares of the company's stock worth $4,629,000 after purchasing an additional 18,490 shares during the period. 54.25% of the stock is owned by institutional investors.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.